MD240Y - Metodă de tratament al dereglărilor cognitive - Google Patents

Metodă de tratament al dereglărilor cognitive Download PDF

Info

Publication number
MD240Y
MD240Y MDS20100058A MDS20100058A MD240Y MD 240 Y MD240 Y MD 240Y MD S20100058 A MDS20100058 A MD S20100058A MD S20100058 A MDS20100058 A MD S20100058A MD 240 Y MD240 Y MD 240Y
Authority
MD
Moldova
Prior art keywords
cognitive disorders
cerebral hemisphere
iaeeg
micropolarization
projection
Prior art date
Application number
MDS20100058A
Other languages
English (en)
Russian (ru)
Inventor
Виктор ЛАКУСТА
Анжела ГЫЛЯ
Виктория ЧЕРЕШ
Original Assignee
Виктор ЛАКУСТА
Анжела ГЫЛЯ
Виктория ЧЕРЕШ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Виктор ЛАКУСТА, Анжела ГЫЛЯ, Виктория ЧЕРЕШ filed Critical Виктор ЛАКУСТА
Priority to MDS20100058A priority Critical patent/MD240Y/ro
Publication of MD240Y publication Critical patent/MD240Y/ro

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Invenţia se referă la medicină, în special la neurologia cognitivă, şi poate fi utilizată pentru corecţia dereglărilor cognitive.Metoda de tratament al dereglărilor cognitive constă în efectuarea electroencefalografiei, după care în baza datelor obţinute în derivaţia frontală F3 pentru emisfera cerebrală stângă şi în derivaţia frontală F4 pentru emisfera cerebrală dreaptă se determină indicele integral al electroencefalogramei (IEEG). Apoi se determină gradul asimetriei interemisferice (AIEEG) şi dacă AIEEG este mai mic de 10%, iar IEEGF3 şi/sau IEEGF4 este mai mare de 0,7, atunci se efectuează micropolarizarea proiecţiei vermisului cerebelar, dacăAIEEG este mai mare de 10%, iar IEEGF3 este mai mare de 0,7, se efectuează micropolarizarea proiecţiei emisferei cerebelare drepte şi, respectiv, dacă IEEGF4 este mai mare de 0,7, se efectuează micropolarizarea proiecţiei emisferei cerebelare stângi.
MDS20100058A 2010-03-29 2010-03-29 Metodă de tratament al dereglărilor cognitive MD240Y (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100058A MD240Y (ro) 2010-03-29 2010-03-29 Metodă de tratament al dereglărilor cognitive

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100058A MD240Y (ro) 2010-03-29 2010-03-29 Metodă de tratament al dereglărilor cognitive

Publications (1)

Publication Number Publication Date
MD240Y true MD240Y (ro) 2010-07-31

Family

ID=43569027

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100058A MD240Y (ro) 2010-03-29 2010-03-29 Metodă de tratament al dereglărilor cognitive

Country Status (1)

Country Link
MD (1) MD240Y (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD465Z (ro) * 2011-06-07 2012-08-31 Виктор ЛАКУСТА Metodă de tratament al dereglărilor cognitiv-afective la bolnavii cu migrenă cronică şi asimetria ventriculelor cerebrale laterale

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3504G2 (ro) * 2007-05-31 2009-03-31 Виктор ЛАКУСТА Metodă de micropolarizare transcraniană
  • 2010

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3504G2 (ro) * 2007-05-31 2009-03-31 Виктор ЛАКУСТА Metodă de micropolarizare transcraniană

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD465Z (ro) * 2011-06-07 2012-08-31 Виктор ЛАКУСТА Metodă de tratament al dereglărilor cognitiv-afective la bolnavii cu migrenă cronică şi asimetria ventriculelor cerebrale laterale

Similar Documents

Publication Publication Date Title
EA201270803A1 (ru) Тиоацетатные соединения, композиции на их основе и способы их применения
PH12017500402A1 (en) Anti-glucagon antibodies and uses thereof
Brekke et al. Patient mobility, health care quality and welfare
HK1213291A1 (zh) 用於治療胱氨酸尿症的胱硫醚β合酶
PH12018501288A1 (en) Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels
MX356958B (es) Análogos de péptido-2 tipo glucagón (glp-2).
GEP20166554B (en) Nitrogenated heterocyclic compound
EA201891152A1 (ru) Экстрацеллюлярные везикулы нервных клеток
MX365294B (es) Inhibidores de proteína cinasa dependiente de adn.
EA201590849A1 (ru) Композиции, способы и применения для лечения диабета и связанных состояний посредством контроля уровня глюкозы крови
PH12015500114A1 (en) HUMAN ANTIBODIES TO GFRa3 AND METHODS OF USE THEREOF
WO2017031067A3 (en) Biomarkers for treatment of alopecia areata
MX2017009091A (es) Complejos de metal y desferroxiamina para el tratamiento de trastornos relacionados con la inmunidad.
CA2863417A1 (en) Innate immune proteins as biomarkers for cns injury
HK1250171A1 (zh) 使用环化的配对文库和鸟枪测序检测基因组变异的方法
WO2012065110A3 (en) S-protected cysteine analogs and related compounds
PH12014501613A1 (en) Anti-asic1 antibodies and uses thereof
EA201390704A1 (ru) Соединения, ингибирующие металлоферменты
WO2012074561A3 (en) Methods and compositions for the treatment of anxiety disorders, including post traumatic stress disorder (ptsd) and related central nervous system (cns) disorders
MX2022003128A (es) Metodos de tratamiento de trastornos neurodegenerativos en una poblacion de pacientes particular.
PH12015502687A1 (en) Marker for acid sphingomyelinase disorders and uses thereof
GB2557471A (en) Arginine silicate inositol for improving cognitive function
EA201500294A1 (ru) Ноотропные композиции для улучшения свойств памяти
WO2014166303A3 (en) Use of multiomic signature to predict diabetes
NZ708648A (en) Learning and memory improver

Legal Events

Date Code Title Description
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)